Navigation Links
Sigma-tau's Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture
Date:11/27/2012

NEW DELHI, November 27, 2012 /PRNewswire/ --

The project team for Eurartesim®, dihydroartemisinin-piperaquine (DHA-PQP), the first novel chemical entity developed by Sigma-Tau was awarded Medicines for Malaria (MMV) Project of the Year 2011, the latter is a non-profit body with significant contribution from the Bill& Melinda Gates foundation. The award was presented in new Delhi during MMV's international stakeholder meeting.

Representatives of the Italian pharma group - Prof. Trevor Jones, Dr Marco Corsi & Dr Andreas Diedenhofen - accepted the prize and expressed satisfaction on behalf of the entire team for the achievement.

MMV established the "Project of the Year" award more than a decade ago to recognize the efforts of selected teams working to combat malaria worldwide. Winners are selected by MMV's Expert Scientific Advisory Committee, a group of world renowned experts in malaria and drug development.

Having received European Medicines Agency (EMA) approval in 2011, Eurartesim can now be used safely and effectively, and be deployed widely. The first shipment of 160,000 packages of Eurartesim to a malaria-endemic country were delivered to Cambodia in July this year, where it is hoped the medicine will help to delay the development of artemisinin drug resistance emerging in the region.

The drug is already available in Europe and has a series of advantages over other artemisinin-based combination therapies (ACTs) given that it's easier to administer - once a day for three days- rather than other medicines which need to be taken twice a day. owing to the long half-life of piperaquine, Eurartesim® offers better and longer protection from new malaria infections.

Sigma-Tau Group

Sigma-Tau is a leading, all Italian capital, International pharmaceutical Group, founded in 1957, that invests in the research, development and marketing of innovative and effective treatments to improve human well-being and quality of life. Sigma-Tau Group has headquarters in Pomezia (Rome, Italy), and subsidiaries in France, Switzerland, the Netherlands, Belgium, Portugal, Germany, UK, India, and with production plant in Italy as well as in Spain and US (Indianapolis); with about 2400 employees and an extensive network of licensees worldwide achieved a global turnover of € 663 million in 2011.

Website:http://www.sigma-tau.it

Sigma-Tau Press Office Evolution
Bruno Chiavazzo, Head of Communication and Information
E-mail: bruno.chiavazzo@sigma-tau.it
Phone +39-(0)6-91393963
PR
Rudra Chakraborty
Email: rudra.chakraborty@evolutionpr.it
Phone +39-3317671004



'/>"/>
SOURCE Sigma-Tau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Reveals Extent of Poor-Quality Antimalarial Medicines in South American Countries
2. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
3. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
4. Breast Cancer Survivor Awarded Top Prize In 2012 Oncology On Canvas(SM) Art Competition
5. New Snoring Therapy Awarded The Prestigious Spark Award
6. Harrisvaccines Awarded Vaccine Product Licensure
7. Healionics Awarded $900k Grant from NIH
8. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
9. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
10. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
11. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)...  A research team led by St. Jude ... how the abnormal breakage and rearrangement of chromosomes in ... acute lymphoblastic leukemia (ALL). Such leukemias are cancers of ... of immature cells, called lymphoblasts. --> ... underlying the type called "Ph-like ALL" will aid in ...
(Date:2/8/2016)... DIEGO , Feb. 8, 2016 /PRNewswire/--  Cell ... announced that advanced tissue-engineering services are now available ... a groundbreaking new three-dimensional (3D) bioprinting approach called ... 3D Bio Printer , a state-of-the-art robotic system ... has created a powerful pay-for-service bio-printing model that ...
(Date:2/8/2016)... 2016 http://www.researchandmarkets.com/research/bcrl3s/labelfree ... "Label-Free Detection Market by Technology, Products, ... report to their offering. --> ... the "Label-Free Detection Market by Technology, ... report to their offering. --> ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced expansion into Canada to provide its range of unique and advantaged ... in Quebec City that will provide bilingual customer service and marketing support. A ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... program serving the greater Venice, FL area, has initiated a fundraiser for a ... car accident just four days after Christmas. To support this beautiful child who ...
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s ... booths and 700 companies. Attendees also get to see the most incredible gardens ... & Home Show , at the Colorado Convention Center - 700 14th St. Denver ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
Breaking Medicine News(10 mins):